Quartette

Drug Overview

Quartette is a specialized and highly effective medication within the Gynecology category. It belongs to the Drug Class known as Combined Oral Contraceptives (Extended). Designed to empower women with reliable family planning and greater control over their menstrual cycles, this medication prevents pregnancy while significantly reducing the number of periods a woman experiences each year.

Unlike traditional 28-day birth control pills, Quartette is an extended-cycle Hormone Modulator designed to be taken continuously for 91 days. This allows women to have only four scheduled periods a year. What makes Quartette unique is its “ascending dose” design. The amount of estrogen slightly increases at three specific points during the 84 days of active pills, followed by seven days of a very low-dose estrogen pill instead of a hormone-free placebo. This innovative structure is specifically formulated to help minimize breakthrough bleeding and spotting, which are common challenges with extended-cycle pills.

Key Drug Information:

• Generic Name / Active Ingredients: Levonorgestrel (a progestin) and Ethinyl Estradiol (an estrogen).
• US Brand Names (Equivalents): Quartette, Fayosim, Rivelsa.
• Route of Administration: Oral tablet.
• FDA Approval Status: Fully FDA-approved for prescription use in women of reproductive age.

What Is It and How Does It Work? (Mechanism of Action)

Quartette acts as a sophisticated, systemic Hormone Modulator. By replacing the body’s natural hormone fluctuations with a steady, controlled supply, it safely and reversibly pauses fertility.

At the molecular and hormonal level, this medication prevents pregnancy by modulating the hypothalamic-pituitary-ovarian (HPO) axis in three distinct ways:

• Ovulation Suppression (The Primary Action): The continuous daily dose of synthetic estrogen and progestin provides negative feedback to the hypothalamus and the pituitary gland in the brain. This stops the release of Gonadotropin-Releasing Hormone (GnRH), Luteinizing Hormone (LH), and Follicle-Stimulating Hormone (FSH). Without the required mid-cycle surge of LH, the ovaries are not triggered to mature and release an egg.
• Cervical Mucus Thickening: The levonorgestrel component acts on receptors in the cervix, causing the natural cervical mucus to become thick, sticky, and highly resistant to sperm. This creates a physical roadblock, trapping sperm before they can enter the uterus.
• Endometrial Stabilization and Alteration: Quartette alters the environment of the uterine lining (the endometrium). The ascending dose of ethinyl estradiol keeps the lining structurally stable over the long 84-day stretch, which reduces unexpected spotting. Simultaneously, it keeps the tissue too thin and inactive for a fertilized egg to successfully implant and grow. Furthermore, the 7 days of low-dose estrogen at the end of the pack (instead of completely hormone-free pills) helps prevent the estrogen-withdrawal headaches often experienced during a period.

FDA-Approved Clinical Indications

While primarily formulated for family planning, the extended hormonal control provided by Quartette makes it a highly effective tool for managing several other women’s health conditions that are aggravated by frequent periods.

Primary Gynecological/Obstetric Indications

• Pregnancy Prevention: The primary, fully FDA-approved indication is for use as a daily oral contraceptive to prevent unintended pregnancies.

Off-Label / Endocrinological Indications

• Menstrual Cycle Management: Ideal for women who desire fewer periods per year for personal convenience, military deployment, or athletic performance.
• Dysmenorrhea and Menorrhagia: Frequently prescribed to relieve severe, painful menstrual cramps and to significantly lighten excessively heavy menstrual bleeding by reducing the frequency of periods.
• Endometriosis Management: Used off-label to suppress the monthly growth and shedding of endometrial tissue outside the uterus, significantly reducing pelvic pain.
• Polycystic Ovary Syndrome (PCOS) Management: Helps regulate hormone levels and lower circulating androgens (male-pattern hormones).
• Cancer Risk Reduction: Long-term use of Combined Oral Contraceptives is associated with a significant decrease in the lifetime risk of developing both ovarian and endometrial cancers.

Dosage and Administration Protocols

Quartette is packaged in a specialized 91-day blister pack. It contains 84 active pills where the estrogen dose gradually increases, followed by 7 days of low-dose estrogen pills.

Dose Adjustments and Special Populations:

• Renal Impairment: No specific dose adjustments are required for patients with kidney issues.
• Hepatic Impairment: Strictly contraindicated (do not use) in patients with severe liver disease, liver tumors, or acute viral hepatitis, because steroid hormones are metabolized directly by the liver.

Clinical Efficacy and Research Results

Extended-cycle contraceptives have been extensively studied, and recent clinical reviews (2020-2026) validate the unique benefits of Quartette’s ascending dose regimen.

• Contraceptive Efficacy: When used flawlessly (taking the pill at the exact same time every day without missing doses), the failure rate is less than 1 pregnancy per 100 women per year (Pearl Index < 1.0). With “typical use,” the failure rate is approximately 9%.
• Breakthrough Bleeding Reduction: Clinical trials comparing Quartette’s ascending-dose regimen to standard monophasic 91-day pills show that the gradual increase in estrogen reduces the incidence of unscheduled breakthrough bleeding and spotting by 20% to 30% during the first two 91-day cycles of use.
• Pelvic Pain Improvement: For patients suffering from severe primary dysmenorrhea or endometriosis, the reduction of periods from 13 a year to 4 a year results in Visual Analog Scale (VAS) pain scores decreasing by over 60% annually, drastically improving quality of life.

Safety Profile and Side Effects

BOXED WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS

Cigarette smoking significantly increases the risk of serious cardiovascular side effects from combined oral contraceptive use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked daily. Quartette is strictly contraindicated in women who are over 35 years old and smoke.

Common Side Effects (>10%)

• Unscheduled breakthrough bleeding or spotting (most common during the first 91-day cycle, decreasing significantly over time).
• Nausea or mild stomach upset.
• Breast tenderness, swelling, or sensitivity.
• Mild headaches.

Serious Adverse Events

• Venous Thromboembolism (VTE): Increased risk of deep vein thrombosis (blood clots in the legs) and pulmonary embolism (blood clots in the lungs).
• Cardiovascular Events: Increased risk of stroke and myocardial infarction (heart attack), especially in patients with existing high blood pressure, diabetes, or who smoke.
• Liver Issues: Very rare instances of benign liver tumors or jaundice.

Management Strategies

• Managing Spotting: Patients should continue taking the pill at the same time every day even if spotting occurs. Because this is a 91-day cycle, it may take up to 6 months for the body to fully adjust to having fewer periods.
• Missed Pills: If one active pill is missed, take it as soon as remembered, even if taking two in one day. If two or more active pills are missed, take the most recent missed pill, discard the older ones, and use a backup contraceptive (like condoms) for the next 7 days.
• Emergency Intervention: If severe symptoms occur, such as sudden chest pain, shortness of breath, severe migraines with aura, or leg swelling, patients must stop the medication and seek emergency medical care immediately to rule out a blood clot.

Research Areas

While Quartette utilizes highly established pharmacological pathways rather than modern Biologic or stem cell therapies, the field of hormonal contraception is rapidly advancing. Current Research Areas focus on the long-term impact of continuous synthetic hormones on the regenerative capacity of the uterine lining (endometrium). Scientists are actively studying how the endometrial stem cell niche adapts to extended-cycle Hormone Modulators, aiming to unlock new, non-surgical treatments for complex conditions like endometriosis and adenomyosis. Furthermore, there is a major push toward developing advanced Targeted Therapy systems—such as biodegradable implants or transdermal micro-arrays—that aim to deliver these precise ascending hormone regimens directly to reproductive tissues, minimizing systemic exposure and significantly reducing cardiovascular risks.

Patient Management and Practical Recommendations

Pre-Treatment Tests:

• A comprehensive medical history is essential, specifically screening for a personal or family history of blood clots, high blood pressure, breast cancer, and migraines with aura.
• A baseline blood pressure measurement.
• A routine pregnancy test to ensure the patient is not currently pregnant before initiating the medication.

Precautions During Treatment:

• Symptom Vigilance (ACHES): Patients must be educated on the “ACHES” warning signs. Seek immediate medical help for Abdominal pain (severe), Chest pain, Headaches (severe/migraines), Eye problems (blurred vision/loss of vision), or Severe leg pain.
• Drug Interactions: Certain medications, including broad-spectrum antibiotics, anticonvulsants (anti-seizure drugs), and herbal supplements like St. John’s Wort, can induce liver enzymes and make Quartette less effective at preventing pregnancy.

Do’s and Don’ts List:

• DO set a daily alarm on your phone to take your pill at the exact same time every day. Because you are extending your cycle for 3 months, consistency is absolutely vital to prevent breakthrough bleeding.
• DO use a backup method of birth control (like condoms) if you experience severe vomiting or diarrhea within 3 to 4 hours of taking your pill, as it may not have been fully absorbed.
• DON’T smoke cigarettes while taking this medication, especially as you approach or pass the age of 35.
• DON’T stop taking the pills just because you experience spotting during the first pack. It is very common for the body to need time to adjust to an extended regimen.

Legal Disclaimer

The content provided in this guide is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, gynecologist, or other qualified healthcare provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.